136 items found

Organisations: RISIS2OpenData Tags: CI Cancer EMBASE RCT

Filter Results
  • dataset

    Risk of bias in included studies.

    Risk of bias in included studies were evaluated every element of study design: blinding description, randomization process, inclusion and exclusion criteria, concealed...
  • dataset

    Description of trials of health behaviour change interventions: Physical acti...

    Description of trials of health behaviour change interventions: Physical activity.
  • dataset

    r37980778c78--8b19739e2753def8b6a66cb67abcb57d

    Abbreviation: KPS, karnofsky; SFI, shenqi fuzheng injection; T, treatment; C, control; Y, year; GP, gemcitabine + platinum; TP, taxol + platinum; NP, navelbine + platinum; EP,...
  • dataset

    Reducing HIV-related stigma and discrimination in healthcare settings: A syst...

    IntroductionStigma and discrimination (SAD) related to HIV compromise access and adherence to treatment and support programs among people living with HIV (PLHIV). The ambitious...
  • dataset

    r37980778c78--b56f374a07f1106561957f389aec5e7b

    The time to CNS-progression (P = 0.543).
  • dataset

    r37980778c78--9bd8365f1595a852698527ef048b951f

    BackgroundThe role of surgery in treating small cell lung cancer (SCLC) remains controversial. This meta-analysis aims to determine whether surgical-based treatment improves...
  • dataset

    r37980778c78--fb9375e81707487f9a1162227a0846ed

    Included studies reporting endpoints of interest.
  • dataset

    r37980778c78--7a9ab5fd63d84790b12705219f41e2dd

    AimsSeveral studies reported treatment benefits of tolvaptan in patients with congestive heart failure (CHF). However, the optimal dosage remains unclear. We aimed to compare...
  • dataset

    Effects of intensive blood pressure lowering on mortality and cardiovascular ...

    BackgroundPrevious studies have demonstrated that intensive blood pressure (BP) lowering treatment reduces the risk of all-cause mortality and provides greater vascular...
  • dataset

    The Effectiveness and Safety of Fluoroquinolone-Containing Regimen as a First...

    BackgroundFluoroquinolone is recommended as a pivotal antituberculous agent for treating multi-drug-resistant pulmonary tuberculosis. However, its effectiveness as first-line...
  • dataset

    Baseline characteristics of each included study.

    Baseline characteristics of each included study.
  • dataset

    Direct, indirect, and NMA estimates of all-cause mortality with 95% confidenc...

    Direct, indirect, and NMA estimates of all-cause mortality with 95% confidence intervals and GRADE assessments for each pairwise comparison within the network of seven phosphate...
  • dataset

    The baseline features reported within the included trials.

    Abbreviations: DES: drug eluting stents, BMS: bare metal stents.
  • dataset

    Population characteristics.

    Data are expressed as mean ± standard error or as percentages. Abbreviations: CRP: C-reactive protein, DAS28: disease activity score using 28 joint counts, DMARDs:...
  • dataset

    Efficacy and safety of 5-hydroxytryptamine 3 receptor antagonists in irritabl...

    AimWe assessed the efficacy and safety of 5-hydroxytryptamine (5-HT3) receptor antagonists in adults with non-constipated irritable bowel syndrome (IBS) or diarrhea-predominant...
  • dataset

    Baseline clinical characteristics of trials included in the meta-analysis.

    Baseline clinical characteristics of trials included in the meta-analysis.
  • dataset

    Assessment of randomized controlled trials.

    Assessment of randomized controlled trials.
  • dataset

    A flow chart on selection included of trials in the Meta-analysis.

    A flow chart on selection included of trials in the Meta-analysis.
  • dataset

    Risk of bias assessment.

    Table 2 Assessment of the risk of bias in individual studies based on (1) exposure determination which includes standardization of age and assessment of LUTS severity by IPSS...